Compile Data Set for Download or QSAR
Report error Found 45 Enz. Inhib. hit(s) with all data for entry = 6285
TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120398(US8703771, 11)
Affinity DataIC50: 2.20nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 2.40nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 5.30nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120392(US8703771, 5)
Affinity DataIC50: 5.40nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 5.80nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120390(US8703771, 3)
Affinity DataIC50: 6.20nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120391(US8703771, 4)
Affinity DataIC50: 6.30nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120398(US8703771, 11)
Affinity DataIC50: 8.5nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120398(US8703771, 11)
Affinity DataIC50: 9.60nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120393(US8703771, 6)
Affinity DataIC50: 12nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120390(US8703771, 3)
Affinity DataIC50: 12nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 13nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120396(US8703771, 9)
Affinity DataIC50: 15nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 15nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120391(US8703771, 4)
Affinity DataIC50: 15nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120390(US8703771, 3)
Affinity DataIC50: 16nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 17nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120392(US8703771, 5)
Affinity DataIC50: 18nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120393(US8703771, 6)
Affinity DataIC50: 20nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120397(US8703771, 10)
Affinity DataIC50: 21nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 22nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 22nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120392(US8703771, 5)
Affinity DataIC50: 23nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120402(US8703771, 15)
Affinity DataIC50: 23nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120402(US8703771, 15)
Affinity DataIC50: 24nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120391(US8703771, 4)
Affinity DataIC50: 26nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 32nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120393(US8703771, 6)
Affinity DataIC50: 32nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120397(US8703771, 10)
Affinity DataIC50: 32nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120394(US8703771, 7)
Affinity DataIC50: 41nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120396(US8703771, 9)
Affinity DataIC50: 51nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 53nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 65nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120397(US8703771, 10)
Affinity DataIC50: 70nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120396(US8703771, 9)
Affinity DataIC50: 121nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetPlatelet-derived growth factor receptor beta(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120389(US8703771, 2)
Affinity DataIC50: 233nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 256nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 266nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120394(US8703771, 7)
Affinity DataIC50: 411nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120402(US8703771, 15)
Affinity DataIC50: 526nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120394(US8703771, 7)
Affinity DataIC50: 529nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120389(US8703771, 2)
Affinity DataIC50: 1.19E+3nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120389(US8703771, 2)
Affinity DataIC50: 2.04E+3nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120388(US8703771, 12 | US8703771, 1)
Affinity DataIC50: 2.25E+3nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent

TargetMast/stem cell growth factor receptor Kit(Human)
Harbin Gloria Pharmaceuticals

US Patent
LigandPNGBDBM120395(US8703771, 13 | US8703771, 14 | US8703771, 8)
Affinity DataIC50: 2.26E+3nMpH: 7.5 T: 2°CAssay Description:The activity of the compounds of this invention on Abl, c-Kit and PDGFR kinases was tested by Mobility Shift Assay (MSA). Kinase buffer: 62.5 mM HEPE...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2014
Entry Details
US Patent